Does : Actualité Does en direct - P7 | Bourse Reflex
Accueil > Tags > Does

  • Toutes les actualités en rapport avec « Does »

21/07 18:00 Does - Dynamic growth in H1 2015/16 revenues: +25% of which 16% like-for-like

07/07 18:00 Does - Independent Data Safety Monitoring Board Recommends Continuation per Protocol of Genticel's Phase 2 Clinical Trial of GTL001 (ProCervix), Company's First-in-class HPV Therapeutic Vaccine Candidate

03/07 18:00 Does - Summary of Genticel's liquidity contract with Oddo Corporate Finance

02/07 18:15 Does - Genticel CFO, Martin Koch, Appointed CEO to Replace Benedikt Timmerman during Temporary Medical Leave of Absence

26/06 18:00 Does - RESULTS OF THE STANDING REPURCHASE ORDER FOR HOLDERS OF THE 2015 OCEANE

19/06 08:00 Does - OPENING OF THE STANDING REPURCHASE ORDER FOR HOLDERS OF THE 2015 OCEANE

16/06 19:00 Does - OL GROUPE ANNOUNCES THE SUCCESS OF ITS SHARE CAPITAL INCREASE WITH SHAREHOLDERS' PREFERENTIAL SUBSCRIPTION RIGHTS OF APPROXIMATELY EUR 53 MILLION

16/06 07:00 Does - Genticel Receives FDA Clearance of IND Application for U.S. Phase 1 Clinical Trial of GTL001 (ProCervix), Company's First-in-class HPV Therapeutic Vaccine Candidate

01/06 07:00 Does - Genticel annonce des résultats positifs de preuve de concept préclinique pour GTL002, le nouveau candidat vaccin thérapeutique multivalent HPV issu de Vaxiclase, sa plateforme technologique propriétaire

01/06 07:00 Does - Genticel Announces Positive Preclinical Proof of Concept Results of GTL002, its New Multivalent HPV Therapeutic Vaccine Candidate Based on Company's Versatile Vaxiclase Platform

30/05 13:35 Does - Artprice denies plan to acquire Artnet

27/05 07:45 Does - OL GROUPE ANNOUNCES THE LAUNCH AND THE TERMS AND CONDITIONS OF ITS RIGHTS OFFERING FOR AN AMOUNT OF EUROS 53 MILLION AND THE REPURCHASE PRO-CEDURE OF OUTSTANDING OCEANE DUE 2015(1)

19/05 19:00 Does - Capital increase of EUR 3.0 million following the private placement of an international institutional investor

06/05 17:00 Does - 2015 First Quarter Turnover Up 13.8% at EUR 69.2m

06/05 07:00 Does - THEOLIA's first quarter of 2015 performs as well as the first quarter of 2014

05/05 10:10 Does - PLANNED SHARE CAPITAL INCREASE OF APPROXIMATELY EUR 52,000,000 SUPPORTED BY THE SHAREHOLDERS ICMI AND PATHÉ AND GUARANTEED BY NATIXIS

30/04 07:30 Does - SIGNATURE OF AN AGREEMENT IN RELATION TO THE FINANCIAL RESTRUCTURING OF LATECOERE

28/04 19:00 Does - Business Update - First Quarter 2015

23/04 18:00 Does - Genticel to Participate in SmallCap Event on April 27 - 28 in Paris, France

20/04 18:40 Does - Genticel to Present Further Promising Pharmacology In-Vivo Results of its Phase 2 Immunotherapeutic Vaccine Candidate, GTL001 (ProCervix), at AACR Annual Meeting 2015